Keith Barclay
Chief Investment Officer bei Elasmogen Ltd.
Profil
Keith Barclay currently works at Elasmogen Ltd., as Director & Investor Director and Business Growth Fund Ltd, as Principal from 2015.
Mr. Barclay received his graduate degree from the University of Aberdeen.
Aktive Positionen von Keith Barclay
| Unternehmen | Position | Beginn |
|---|---|---|
Business Growth Fund Ltd
 Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Ltd (BGF) is private equity firm founded in 2011 by Stephen Welton. The firm is headquartered in the UK. | Private Equity Investor | 01.11.2015 |
Elasmogen Ltd.
 Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Elasmogen Ltd. develops soloMER products for treatment of auto-immune mediated and inflammatory diseases. The company is headquartered in Aberdeen, the United Kingdom. | Chief Investment Officer | - |
Ausbildung von Keith Barclay
| University of Aberdeen | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Business Growth Fund Ltd
Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Ltd (BGF) is private equity firm founded in 2011 by Stephen Welton. The firm is headquartered in the UK. | Finance |
Elasmogen Ltd.
Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Elasmogen Ltd. develops soloMER products for treatment of auto-immune mediated and inflammatory diseases. The company is headquartered in Aberdeen, the United Kingdom. | Health Technology |
